MiNK Therapeutics, Inc. (INKT) reported Loss for fourth quarter that decreased from last year but missed the Street estimates.
The company's bottom line totaled -$2.5 million, or -$0.62 per share. This compares with -$5.5 million, or -$1.58 per share, last year.
Analysts on average had expected the company to earn -$0.5 per share. Analysts' estimates typically exclude special items.
MiNK Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$2.5 Mln. vs. -$5.5 Mln. last year.
-EPS: -$0.62 vs. -$1.58 last year.
For comments and feedback: editorial@rttnews.com